The effects of the human renin inhibitor aliskiren on blood pressure (BP), end-organ damage, proteinuria, and tissue and plasma angiotensin (ANG) II levels in young and adult heterozygous Ren-2 transgenic rats (TGR) were evaluated and compared with the effect of the ANG type 1 (AT(1)) receptor blocker losartan during treatment and after 12 days after the withdrawal of drug treatments. BP was monitored by telemetry from the age of 32 days on (young rats) and at 100 days (adult rats). Aliskiren (10 mg·kg(-1)·day(-1) in osmotic minipumps) or losartan (5 mg·kg(-1)·day(-1) in drinking water) treatment was applied for 28 days in young rats and for 70 days in adult rats. In young untreated TGR, severe hypertension rapidly evolved. Adult untreated TGR exhibited stable established hypertension. Both aliskiren and losartan fully prevented the development of hypertension and cardiac hypertrophy in young TGR and normalized BP and cardiac hypertrophy in adult TGR. After cessation of aliskiren treatment in both young and adult TGR BP and cardiac hypertrophy were persistently reduced, while after losartan withdrawal BP and cardiac hypertrophy rapidly increased. In adult aliskiren-treated rats proteinuria was significantly reduced compared with losartan (the effect persisting after withdrawal of treatment), and this decrease strongly correlated with normalization of glomerular size in these animals. In conclusion, aliskiren and losartan had similar antihypertensive effects during chronic treatment, but the antihypertensive and organoprotective effects of aliskiren were persistent even after the 12-day washout period. The durable effect on proteinuria can possibly be attributed to the normalization of glomerular morphology.

Section of Nephrology 1st Medical Faculty Department of Medicine Charles University Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc12026208

003      

CZ-PrNML

005      

20171124111344.0

007      

ta

008      

120817s2010 xxu f 000 0#eng||

009      

AR

024    7_

$a 10.1152/ajprenal.00259.2010 $2 doi

035    __

$a (PubMed)20668096

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Rakušan, Dan $7 xx0219012 $u Section of Nephrology, 1st Medical Faculty, Department of Medicine, Charles University, Prague, Czech Republic.

245    10

$a Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats / $c D. Rakusan, P. Kujal, HJ. Kramer, Z. Husková, Z. Vanourková, Z. Vernerová, I. Mrázová, M. Thumová, L. Cervenka, I. Vanecková,

520    9_

$a The effects of the human renin inhibitor aliskiren on blood pressure (BP), end-organ damage, proteinuria, and tissue and plasma angiotensin (ANG) II levels in young and adult heterozygous Ren-2 transgenic rats (TGR) were evaluated and compared with the effect of the ANG type 1 (AT(1)) receptor blocker losartan during treatment and after 12 days after the withdrawal of drug treatments. BP was monitored by telemetry from the age of 32 days on (young rats) and at 100 days (adult rats). Aliskiren (10 mg·kg(-1)·day(-1) in osmotic minipumps) or losartan (5 mg·kg(-1)·day(-1) in drinking water) treatment was applied for 28 days in young rats and for 70 days in adult rats. In young untreated TGR, severe hypertension rapidly evolved. Adult untreated TGR exhibited stable established hypertension. Both aliskiren and losartan fully prevented the development of hypertension and cardiac hypertrophy in young TGR and normalized BP and cardiac hypertrophy in adult TGR. After cessation of aliskiren treatment in both young and adult TGR BP and cardiac hypertrophy were persistently reduced, while after losartan withdrawal BP and cardiac hypertrophy rapidly increased. In adult aliskiren-treated rats proteinuria was significantly reduced compared with losartan (the effect persisting after withdrawal of treatment), and this decrease strongly correlated with normalization of glomerular size in these animals. In conclusion, aliskiren and losartan had similar antihypertensive effects during chronic treatment, but the antihypertensive and organoprotective effects of aliskiren were persistent even after the 12-day washout period. The durable effect on proteinuria can possibly be attributed to the normalization of glomerular morphology.

650    _2

$a amidy $x farmakologie $7 D000577

650    _2

$a angiotensin II $x krev $7 D000804

650    _2

$a zvířata $7 D000818

650    _2

$a antihypertenziva $x farmakologie $7 D000959

650    _2

$a krevní tlak $x účinky léků $7 D001794

650    _2

$a kardiomegalie $x prevence a kontrola $7 D006332

650    _2

$a modely nemocí na zvířatech $7 D004195

650    _2

$a fumaráty $x farmakologie $7 D005650

650    _2

$a srdeční frekvence $x účinky léků $7 D006339

650    _2

$a hypertenze $x prevence a kontrola $7 D006973

650    _2

$a glomerulus $x účinky léků $x metabolismus $x patologie $7 D007678

650    _2

$a losartan $x farmakologie $7 D019808

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a proteinurie $x patologie $x prevence a kontrola $7 D011507

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a potkani transgenní $7 D055647

650    _2

$a renin $x genetika $x metabolismus $7 D012083

650    _2

$a časové faktory $7 D013997

655    _2

$a srovnávací studie $7 D003160

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1#

$a Kujal, Petr. $7 xx0244311

700    1_

$a Kramer, Herbert J. $7 xx0085908

700    1_

$a Husková, Zuzana, $d 1978- $7 xx0074206

700    1_

$a Vaňourková, Zdeňka, $d 1973- $7 xx0074217

700    1_

$a Vernerová, Zdenka, $d 1960-2020 $7 jo2002104672

700    1#

$a Mrázová, Iveta. $7 xx0227642

700    1#

$a Thumová, Monika. $7 _AN037603

700    1_

$a Červenka, Luděk, $d 1967- $7 xx0037105

700    1_

$a Vaněčková, Ivana, $d 1964- $7 xx0030586

773    0_

$w MED00006005 $t American journal of physiology. Renal physiology $x 1522-1466 $g Roč. 299, č. 4 (2010), s. F758-766

856    41

$u https://pubmed.ncbi.nlm.nih.gov/20668096 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y m $z 0

990    __

$a 20120817 $b ABA008

991    __

$a 20171124111506 $b ABA008

999    __

$a ok $b bmc $g 948250 $s 783554

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2010 $b 299 $c 4 $d F758-766 $e 20100728 $i 1522-1466 $m American journal of physiology. Renal physiology $n Am J Physiol Renal Physiol $x MED00006005

GRA    __

$a NS9703 $p MZ0

LZP    __

$a Pubmed-20120817/10/04